Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts

Quantitative PCR-based strategies are typically effective for monitoring BCR-ABL1 transcript levels in chronic myeloid leukemia (CML). Additionally, some patients treated with tyrosine kinase inhibitors can experience long-term treatment-free remission after discontinuation of the inhibitor. However, this outcome hinges on effectively monitoring the patient’s response to therapy. We present a patient with CML and multiple BCR-ABL1 transcripts, including a rare isoform that lacks qPCR standardization. We describe unexpected discrepancies in transcript quantification, further having an impact on clinical decision-making regarding duration of treatment. To better inform clinical practice, we suggest monitoring patients at the same testing facility to better track transcript trend.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts ; volume:14 ; number:3 ; year:2021 ; pages:1707-1711 ; extent:5
Case reports in oncology ; 14, Heft 3 (2021), 1707-1711 (gesamt 5)

Urheber
Smith, Brittany M.
Brewer, Diana
Druker, Brian J.
Braun, Theodore P.

DOI
10.1159/000520400
URN
urn:nbn:de:101:1-2022011223393933873397
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekt beim Datenpartner anzeigen

Beteiligte

  • Smith, Brittany M.
  • Brewer, Diana
  • Druker, Brian J.
  • Braun, Theodore P.

Ähnliche Objekte (12)